Shell Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Shell Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,513	Closed	-$341K	–	1272
2019 Q3	$341K	Hold	3,513	–	–	0.01%	1034
2019 Q2	$360K	Hold	3,513	–	–	0.01%	1028
2019 Q1	$400K	Hold	3,513	–	–	0.01%	991
2018 Q4	$137K	Sell	3,513 -300	-8%	-$13K	﹤0.01%	1071
2018 Q3	$208K	Buy	+3,813	New	+$261K	﹤0.01%	1098

Shell Asset Management's ONCE Position: Q4 2019 in Review

Shell Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 3,513 shares — an estimated $341K sold.

Shell Asset Management first reported a position in ONCE in Q3 2018 and held it in 5 quarters. The position peaked at $400K in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Shell Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Shell Asset Management sold 3,513 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $341K.
Shell Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Shell Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $400K in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Shell Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.